← Evidence map

ArticleOncotarget2015

NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor.

Elena Galvani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26015408